19,587 Shares in Transcat, Inc. (NASDAQ:TRNS) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 19,587 shares of the scientific and technical instruments company's stock, valued at approximately $2,071,000. Raymond James Financial Inc. owned 0.21% of Transcat as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Victory Capital Management Inc. raised its stake in Transcat by 1.4% in the 4th quarter. Victory Capital Management Inc. now owns 34,710 shares of the scientific and technical instruments company's stock valued at $3,670,000 after acquiring an additional 480 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of Transcat by 1.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 75,700 shares of the scientific and technical instruments company's stock worth $8,005,000 after buying an additional 868 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in shares of Transcat by 686.7% during the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after buying an additional 309 shares during the last quarter. Morgan Dempsey Capital Management LLC bought a new stake in shares of Transcat during the 4th quarter worth about $143,000. Finally, Rice Hall James & Associates LLC grew its stake in Transcat by 40.2% in the 4th quarter. Rice Hall James & Associates LLC now owns 35,685 shares of the scientific and technical instruments company's stock valued at $3,773,000 after buying an additional 10,238 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors.

Remove Ads

Insiders Place Their Bets

In other news, Director Craig D. Cairns purchased 1,200 shares of the business's stock in a transaction dated Friday, January 31st. The stock was bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the acquisition, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. The trade was a 169.01 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Northland Securities restated a "market perform" rating and set a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. HC Wainwright reduced their price target on Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research note on Wednesday, January 29th. Oppenheimer lowered Transcat from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 29th. StockNews.com downgraded Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. Finally, Craig Hallum upped their price target on shares of Transcat from $113.00 to $125.00 and gave the company a "buy" rating in a research note on Thursday, December 12th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Transcat presently has a consensus rating of "Hold" and an average target price of $111.50.

Transcat Price Performance

NASDAQ:TRNS traded down $2.59 during trading hours on Thursday, reaching $72.77. 115,751 shares of the company were exchanged, compared to its average volume of 69,287. The company has a market capitalization of $677.42 million, a P/E ratio of 39.34 and a beta of 0.66. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The business has a 50 day moving average of $77.56 and a 200 day moving average of $99.68. Transcat, Inc. has a 1-year low of $67.56 and a 1-year high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last released its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter last year, the company posted $0.56 EPS. Research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current year.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.